AleraCare and PURE Healthcare to merge, creating a 75-location
nationwide ambulatory infusion leader enhancing access and outcomes.
Phoenix
& Taylorsville, Utah: AleraCare,
a prominent provider of infusion and specialty pharmacy services, and PURE
Healthcare, a national medical group specializing in complex chronic and
autoimmune conditions, have announced a definitive agreement to merge.
Financial terms were not disclosed.
The combined organization will operate
more than 75 outpatient infusion locations across 14 U.S. states, offering an
expanded network to deliver high-quality, cost-effective care. The merger aims
to enhance patient outcomes, improve access to infusion services, and reduce
overall healthcare costs.
Founded in 2019, AleraCare operates
ambulatory infusion centers, home infusion therapy, and specialty pharmacy
services, maintaining strong partnerships with physicians, payors, and
pharmaceutical manufacturers. PURE Healthcare, established in 2018, is known
for its Pure Infusion Suites—private, patient-focused treatment spaces designed
to improve comfort and affordability, while streamlining administrative
processes for providers and insurers.
The transaction is expected to close in
Q4 2025, pending regulatory approvals and customary closing conditions,
including clearance under the Hart-Scott-Rodino Antitrust Improvements Act.
Holland & Knight is advising AleraCare, while PURE Healthcare is
represented by Kunzler Bean & Adamson, with Cantor Fitzgerald serving as
financial advisor.
According to TechSci
Research, the
merger between AleraCare and PURE Healthcare is poised to significantly benefit
the U.S. healthcare industry by creating one of the largest and most accessible
ambulatory infusion platforms in the country. With over 75 outpatient locations
across 14 states, the combined entity will expand access to high-quality,
cost-effective infusion therapy for patients with complex chronic and
autoimmune conditions, including rheumatoid arthritis, multiple sclerosis,
Crohn’s disease, and Alzheimer’s disease. By integrating AleraCare’s established
network and specialty pharmacy services with PURE Healthcare’s patient-centered
Pure Infusion Suites, the merger will enhance clinical outcomes, improve
patient comfort, and streamline the treatment process. The expanded scale will
also foster stronger partnerships with physicians, payors, and pharmaceutical
manufacturers, enabling more efficient care coordination and lowering overall
healthcare costs. Furthermore, the combined expertise in managing
authorizations and administrative processes will reduce provider burden,
ultimately ensuring a more seamless, patient-focused infusion therapy
experience nationwide.